These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23333012)

  • 21. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
    Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
    J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery.
    Niranjan A; Mathieu D; Flickinger JC; Kondziolka D; Lunsford LD
    Neurosurgery; 2008 Dec; 63(6):1054-62; discussion 1062-3. PubMed ID: 19057318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma.
    Chung HT; Ma R; Toyota B; Clark B; Robar J; McKenzie M
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1116-21. PubMed ID: 15234046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy for vestibular schwannomas.
    Mulder JJ; Kaanders JH; van Overbeeke JJ; Cremers CW
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):367-71. PubMed ID: 22931906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.
    Paek SH; Chung HT; Jeong SS; Park CK; Kim CY; Kim JE; Kim DG; Jung HW
    Cancer; 2005 Aug; 104(3):580-90. PubMed ID: 15952200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
    Söderlund Diaz L; Hallqvist A
    J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
    Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
    J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiosurgery for acoustic neuromas: what happens long term?
    Roos DE; Potter AE; Brophy BP
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1352-5. PubMed ID: 21700400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiotherapy for the treatment of acoustic neuromas.
    Selch MT; Pedroso A; Lee SP; Solberg TD; Agazaryan N; Cabatan-Awang C; DeSalles AA
    J Neurosurg; 2004 Nov; 101 Suppl 3():362-72. PubMed ID: 15537191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.
    Fuss M; Debus J; Lohr F; Huber P; Rhein B; Engenhart-Cabillic R; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1381-7. PubMed ID: 11121637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy.
    Chopra R; Kondziolka D; Niranjan A; Lunsford LD; Flickinger JC
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):845-51. PubMed ID: 17379451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases.
    Hansasuta A; Choi CY; Gibbs IC; Soltys SG; Tse VC; Lieberson RE; Hayden MG; Sakamoto GT; Harsh GR; Adler JR; Chang SD
    Neurosurgery; 2011 Dec; 69(6):1200-9. PubMed ID: 21558974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.
    Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.
    Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic radiotherapy for trigeminal schwannomas.
    Champ CE; Mishra MV; Shi W; Siglin J; Werner-Wasik M; Andrews DW; Evans JJ
    Neurosurgery; 2012 Aug; 71(2):270-7; discussion 277. PubMed ID: 22472550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.
    Champ CE; Shen X; Shi W; Mayekar SU; Chapman K; Werner-Wasik M; Farrell CJ; Gunn V; Downes MB; Liu H; Evans JJ; Andrews DW
    Neurosurgery; 2013 Sep; 73(3):489-96. PubMed ID: 23756743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
    Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
    J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.